"Rosuvastatin Calcium" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES.
| Descriptor ID |
D000068718
|
| MeSH Number(s) |
D02.065.884.650 D02.455.526.510.432.500 D02.886.590.700.650 D03.383.742.775
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Rosuvastatin Calcium".
Below are MeSH descriptors whose meaning is more specific than "Rosuvastatin Calcium".
This graph shows the total number of publications written about "Rosuvastatin Calcium" by people in this website by year, and whether "Rosuvastatin Calcium" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 0 | 3 | 3 |
| 2016 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rosuvastatin Calcium" by people in Profiles.
-
Kallistatin levels in HIV-infected patients and effects of statin therapy. Biomarkers. 2017 Feb; 22(1):55-62.
-
Statins to improve cardiovascular outcomes in treated HIV infection. Curr Opin Infect Dis. 2016 Feb; 29(1):1-9.
-
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction. Circulation. 2015 Jan 06; 131(1):43-53.
-
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial. Am Heart J. 2014 Nov; 168(5):682-9.
-
Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy. J Infect Dis. 2014 Apr 15; 209(8):1156-64.